The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications
{{output}}
Splenic marginal zone lymphoma (SMZL) is a rare, predominantly indolent B-cell lymphoma constituting fewer than 2% of lymphoid neoplasms. However, around 30% of patients have a shorter survival despite currently available treatments and the prognosis is especi... ...
